• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

Pharma & HealthcareGlobal Infectious Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2414281
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 115 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.

Scope of the Report:

This report focuses on the Infectious Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.

The worldwide market for Infectious Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

CSL Limited (Australia)

Bavarian Nordic (Denmark)

GlaxoSmithKline plc. (U.K.)

Emergent Bio Solutions Inc. (U.S.)

MedImmune LLC (U.S.)

Johnson and Johnson (U.S.)

Novartis AG (Switzerland)

Merck and Company (U.S.)

Sanofi Pasteur (France)

Pfizer Inc. (U.S.)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Preventive vaccine

Therapeutic vaccine

Market Segment by Applications, can be divided into

Adults

Pediatrics

There are 15 Chapters to deeply display the global Infectious Vaccines market.

Chapter 1, to describe Infectious Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Infectious Vaccines, with sales, revenue, and price of Infectious Vaccines, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Infectious Vaccines, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Infectious Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Infectious Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

1 Market Overview

1.1 Infectious Vaccines Introduction

1.2 Market Analysis by Type

1.2.1 Preventive vaccine

1.2.2 Therapeutic vaccine

1.3 Market Analysis by Applications

1.3.1 Adults

1.3.2 Pediatrics

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 CSL Limited (Australia)

2.1.1 Business Overview

2.1.2 Infectious Vaccines Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 CSL Limited (Australia) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bavarian Nordic (Denmark)

2.2.1 Business Overview

2.2.2 Infectious Vaccines Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline plc. (U.K.)

2.3.1 Business Overview

2.3.2 Infectious Vaccines Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Emergent Bio Solutions Inc. (U.S.)

2.4.1 Business Overview

2.4.2 Infectious Vaccines Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 MedImmune LLC (U.S.)

2.5.1 Business Overview

2.5.2 Infectious Vaccines Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 MedImmune LLC (U.S.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson and Johnson (U.S.)

2.6.1 Business Overview

2.6.2 Infectious Vaccines Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Novartis AG (Switzerland)

2.7.1 Business Overview

2.7.2 Infectious Vaccines Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Novartis AG (Switzerland) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Merck and Company (U.S.)

2.8.1 Business Overview

2.8.2 Infectious Vaccines Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Merck and Company (U.S.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Sanofi Pasteur (France)

2.9.1 Business Overview

2.9.2 Infectious Vaccines Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sanofi Pasteur (France) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Pfizer Inc. (U.S.)

2.10.1 Business Overview

2.10.2 Infectious Vaccines Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Infectious Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Infectious Vaccines Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Infectious Vaccines Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Infectious Vaccines Manufacturer Market Share in 2017

3.3.2 Top 6 Infectious Vaccines Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Infectious Vaccines Market Analysis by Regions

4.1 Global Infectious Vaccines Sales, Revenue and Market Share by Regions

4.1.1 Global Infectious Vaccines Sales and Market Share by Regions (2013-2018)

4.1.2 Global Infectious Vaccines Revenue and Market Share by Regions (2013-2018)

4.2 North America Infectious Vaccines Sales and Growth Rate (2013-2018)

4.3 Europe Infectious Vaccines Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Infectious Vaccines Sales and Growth Rate (2013-2018)

4.5 South America Infectious Vaccines Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Infectious Vaccines Sales and Growth Rate (2013-2018)

5 North America Infectious Vaccines by Countries

5.1 North America Infectious Vaccines Sales, Revenue and Market Share by Countries

5.1.1 North America Infectious Vaccines Sales and Market Share by Countries (2013-2018)

5.1.2 North America Infectious Vaccines Revenue and Market Share by Countries (2013-2018)

5.2 United States Infectious Vaccines Sales and Growth Rate (2013-2018)

5.3 Canada Infectious Vaccines Sales and Growth Rate (2013-2018)

5.4 Mexico Infectious Vaccines Sales and Growth Rate (2013-2018)

6 Europe Infectious Vaccines by Countries

6.1 Europe Infectious Vaccines Sales, Revenue and Market Share by Countries

6.1.1 Europe Infectious Vaccines Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Infectious Vaccines Revenue and Market Share by Countries (2013-2018)

6.2 Germany Infectious Vaccines Sales and Growth Rate (2013-2018)

6.3 UK Infectious Vaccines Sales and Growth Rate (2013-2018)

6.4 France Infectious Vaccines Sales and Growth Rate (2013-2018)

6.5 Russia Infectious Vaccines Sales and Growth Rate (2013-2018)

6.6 Italy Infectious Vaccines Sales and Growth Rate (2013-2018)

7 Asia-Pacific Infectious Vaccines by Countries

7.1 Asia-Pacific Infectious Vaccines Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Infectious Vaccines Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Infectious Vaccines Revenue and Market Share by Countries (2013-2018)

7.2 China Infectious Vaccines Sales and Growth Rate (2013-2018)

7.3 Japan Infectious Vaccines Sales and Growth Rate (2013-2018)

7.4 Korea Infectious Vaccines Sales and Growth Rate (2013-2018)

7.5 India Infectious Vaccines Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Infectious Vaccines Sales and Growth Rate (2013-2018)

8 South America Infectious Vaccines by Countries

8.1 South America Infectious Vaccines Sales, Revenue and Market Share by Countries

8.1.1 South America Infectious Vaccines Sales and Market Share by Countries (2013-2018)

8.1.2 South America Infectious Vaccines Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Infectious Vaccines Sales and Growth Rate (2013-2018)

8.3 Argentina Infectious Vaccines Sales and Growth Rate (2013-2018)

8.4 Colombia Infectious Vaccines Sales and Growth Rate (2013-2018)

9 Middle East and Africa Infectious Vaccines by Countries

9.1 Middle East and Africa Infectious Vaccines Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Infectious Vaccines Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Infectious Vaccines Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Infectious Vaccines Sales and Growth Rate (2013-2018)

9.3 UAE Infectious Vaccines Sales and Growth Rate (2013-2018)

9.4 Egypt Infectious Vaccines Sales and Growth Rate (2013-2018)

9.5 Nigeria Infectious Vaccines Sales and Growth Rate (2013-2018)

9.6 South Africa Infectious Vaccines Sales and Growth Rate (2013-2018)

10 Global Infectious Vaccines Market Segment by Type

10.1 Global Infectious Vaccines Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Infectious Vaccines Sales and Market Share by Type (2013-2018)

10.1.2 Global Infectious Vaccines Revenue and Market Share by Type (2013-2018)

10.2 Preventive vaccine Sales Growth and Price

10.2.1 Global Preventive vaccine Sales Growth (2013-2018)

10.2.2 Global Preventive vaccine Price (2013-2018)

10.3 Therapeutic vaccine Sales Growth and Price

10.3.1 Global Therapeutic vaccine Sales Growth (2013-2018)

10.3.2 Global Therapeutic vaccine Price (2013-2018)

11 Global Infectious Vaccines Market Segment by Application

11.1 Global Infectious Vaccines Sales Market Share by Application (2013-2018)

11.2 Adults Sales Growth (2013-2018)

11.3 Pediatrics Sales Growth (2013-2018)

12 Infectious Vaccines Market Forecast (2018-2023)

12.1 Global Infectious Vaccines Sales, Revenue and Growth Rate (2018-2023)

12.2 Infectious Vaccines Market Forecast by Regions (2018-2023)

12.2.1 North America Infectious Vaccines Market Forecast (2018-2023)

12.2.2 Europe Infectious Vaccines Market Forecast (2018-2023)

12.2.3 Asia-Pacific Infectious Vaccines Market Forecast (2018-2023)

12.2.4 South America Infectious Vaccines Market Forecast (2018-2023)

12.2.5 Middle East and Africa Infectious Vaccines Market Forecast (2018-2023)

12.3 Infectious Vaccines Market Forecast by Type (2018-2023)

12.3.1 Global Infectious Vaccines Sales Forecast by Type (2018-2023)

12.3.2 Global Infectious Vaccines Market Share Forecast by Type (2018-2023)

12.4 Infectious Vaccines Market Forecast by Application (2018-2023)

12.4.1 Global Infectious Vaccines Sales Forecast by Application (2018-2023)

12.4.2 Global Infectious Vaccines Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Infectious Vaccines . Industry analysis & Market Report on Infectious Vaccines is a syndicated market report, published as Global Infectious Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Infectious Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,480.00
$5,220.00
$6,960.00
2,336.82
3,505.23
4,673.64
3,202.30
4,803.44
6,404.59
421,567.20
632,350.80
843,134.40
230,770.63
346,155.95
461,541.26
Add To Cart Credit card Logo

Related Reports


Reason to Buy